scholarly journals Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study

2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Kunchok Dorjee ◽  
Sanjiv M. Baxi ◽  
Arthur L. Reingold ◽  
Alan Hubbard
AIDS Care ◽  
2004 ◽  
Vol 16 (2) ◽  
pp. 219-230 ◽  
Author(s):  
B. D Heckman ◽  
S. L. Catz ◽  
T. G. Heckman ◽  
J. G. Miller ◽  
S. C. Kalichman

2019 ◽  
Vol 24 (6) ◽  
pp. 1701-1708 ◽  
Author(s):  
Jacob J. Wainwright ◽  
◽  
Linda Beer ◽  
Yunfeng Tie ◽  
Jennifer L. Fagan ◽  
...  

Author(s):  
Robert E Fullilove

This chapter discusses the unique impact that social disadvantage in general and the criminal justice systems in the United States in particular have on the conditions that drive the HIV/AIDS epidemic in this country. HIV/AIDS is classified as an important racial/ethnic health disparity because residents of marginalized black and Hispanic communities are overrepresented among persons living with HIV/AIDS in the United States. Members of black and Hispanic communities are also overrepresented in the criminal justice; in terms of the epidemic, approximately one out of seven persons living with HIV/AIDS will pass through a U.S. correctional facility in any given year. A history of incarceration is associated with poor treatment outcomes for HIV illness. Improving the quality of HIV care in correctional facilities and in the communities to which incarcerated persons will return is imperative, as is effective interventions in incarcerated populations and communities. Having AIDS activists, scientists, and healthcare workers join in efforts to reform incarceration policies and practices will improve efforts to prevent and treat HIV/AIDS, particularly in communities that confront high rates of HIV/AIDS and incarceration.


2016 ◽  
Vol 72 (5) ◽  
pp. 552-557 ◽  
Author(s):  
Qiang Xia ◽  
Sarah L. Braunstein ◽  
Ellen W. Wiewel ◽  
Joanna J. Eavey ◽  
Colin W. Shepard ◽  
...  

Gland Surgery ◽  
2021 ◽  
Vol 0 (0) ◽  
pp. 0-0
Author(s):  
Mohammad Hussein ◽  
Eman Toraih ◽  
Adin S. C. Reisner ◽  
Peter Miller ◽  
Ralph Corsetti ◽  
...  

2020 ◽  
Vol 8 ◽  
pp. 205031212091540
Author(s):  
Lisa Fleischer ◽  
Ann Avery

Objectives: Based on the 2015 U.S. Centers for Disease Control and Prevention data, 40% of people living with HIV in the United States with an HIV diagnosis and 18.5% of people living with HIV in HIV care in the United States are not virally suppressed. Many HIV care clinics have implemented recommendations to improve the percentage of people living with HIV on antiretroviral therapy. To understand what more could be done, we examine patients’ motivations and obstacles to maintaining adherence to antiretroviral therapy. Methods: We conducted qualitative analysis using a qualitative description framework of in-depth interviews with people living with HIV receiving care at an urban HIV care clinic in the midwestern United States. Results: We found that while many traditional barriers to care have been addressed by existing programs, there are key differences between those consistent with antiretroviral therapy and those inconsistent with antiretroviral therapy. In particular, self-motivation, diagnosis acceptance, treatment for depression, spiritual beliefs, perceived value of the HIV care team, and prior experience with health care distinguish these two groups. Most significantly, we found that people living with HIV consistent with antiretroviral therapy describe their main motivation as coming from themselves, whereas people living with HIV inconsistent with antiretroviral therapy more often describe their main motivation as coming from the HIV care team. Conclusion: Our results highlight the importance of the HIV care team’s encouragement of maintaining antiretroviral adherence, as well as encouraging treatment for depression.


Sign in / Sign up

Export Citation Format

Share Document